Novel CRISPR therapy is poised to gain first FDA approval to alter genes inside the body

2026-11-13来源 Nature NewsEnglish

Nature, Published online: 12 November 2026; doi:10.1038/d41586-026-03705-9

Earlier CRISPR treatments require removal of a participant’s cells, a complex and costly approach.

原文：https://www.a8q9.cn/en/article/novel-crispr-therapy-is-poised-to-gain-first-fda-approval-to-alter-genes-inside--3d29b2.html

相关文章